ARTICLE | Clinical News
PCA regulatory update
October 1, 2001 7:00 AM UTC
Odyssey received U.S. Patent No. 6,294,330 covering the use of protein fragment complementation assays to identify and characterize protein-protein and drug-protein interactions in cells. The technolo...